1-5 of 5
Lu Zhou
Close
Sort by
Journal Articles

Real-World Evidence of Avatrombopag for the Treatment of Immune Thrombocytopenia Intolerant or Ineffective to Eltrombopag/Hetrombopag

Hong Tian, Yun Li, Xin Lv, Lu Zhou, Depei Wu, Ziqiang Yu, Jie Yin
Journal: Blood
Blood (2023) 142 (Supplement 1): 2594.
https://doi.org/10.1182/blood-2023-185698
Published: 2023
Journal Articles

Cloned antibodies from patients with HIT provide new clues to HIT pathogenesis

Wen Zhu, Yongwei Zheng, Mei Yu, Yaling Wu, Jianhui Wei, Lu Zhou, Guoping Fu, Nicholas Schneider, Curtis Jones, Mehraboon Irani, Anand Padmanabhan, Richard Aster, Demin Wang, Renren Wen
Journal: Blood
Blood (2023) 141 (9): 1060–1069.
https://doi.org/10.1182/blood.2022017612
Published: 2023
Includes: Supplemental data
Journal Articles

Polyreactivity and Somatic Hypermutation Analysis Reveals the Innate B Cell Origin of Human PF4/Heparin Reactive Antibodies

Wen Zhu, MBBS,MS, Lu Zhou, Ting Zhao, Yongwei Zheng, PhD, Mei Yu, PhD, Jianhui Wei, Anand Padmanabhan, M.B.B.S., PhD, Richard H. Aster, MD, Demin Wang, PhD, Renren Wen, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 34–35.
https://doi.org/10.1182/blood-2020-138781
Published: 2020
Journal Articles

Phosphoglycerate Mutase 1 Promotes Leukemia Metabolism by Coordinating Glycolysis and Biosynthesis, and Represnts a Therapuetic Target in Leukemia Treatment

Taro Hitosugi, PhD, Lu Zhou, PhD, Jun Fan, PhD, Martha Arellano, MD, Hanna J. Khoury, MD, Benjamin H. Lee, MD, PhD, Titus Boggon, PhD, Sumin Kang, PhD, Chuan He, Jing Chen, PhD
Journal: Blood
Blood (2012) 120 (21): 860.
https://doi.org/10.1182/blood.V120.21.860.860
Published: 2012
Journal Articles

γ-IFN May Act As a Positive Regulator to Hematogenesis Through PI3K/Akt and JAK2/STAT5 Pathways

Hong Liu, MD, Lu Zhou, MD, Han Wang
Journal: Blood
Blood (2011) 118 (21): 4785.
https://doi.org/10.1182/blood.V118.21.4785.4785
Published: 2011